Evgen Pharma (GB:EVG) has released an update.
Evgen Pharma PLC, a clinical stage drug development company, has announced its official name change to TheraCryf PLC, effective from 26 April 2024. Alongside its rebranding, the company will also update its AIM ticker to TCF and launch a new corporate website at www.theracryf.com.
For further insights into GB:EVG stock, check out TipRanks’ Stock Analysis page.
